For many college seniors, school is a period for self-exploration, considering options, leisurely contemplating the future. Yet that’s rarely the case for computer engineering students who either attend the world’s best universities or rise to the very top of…
The nonprofit has identified hundreds of profiles that espouse hate, with little attempt from the gaming platform to stop them.
Microsoft has developed a "thin client" version of Windows that seems a lot like Chrome OS. But there are plenty of differences that matter. Back when the world first saw the Microsoft Surface Duo (a folding device that runs Android) and the Surface Neo (a l…
The company decided to pull the trigger on a combined offering of stock and debt to pad its balance sheet during uncertain times.
The photographer won a World Press Photo award for his picture of Kawhi Leonard’s miraculous buzzer-beating shot to push the Raptors to the Eastern Conference finals
Realme is expanding into the “lifestyle tech” market with products in new categories for India. The lineup includes smart TVs, a watch, and more.
Investing in stocks might not make you rich overnight, or even over the course of a few years. With that in mind, here are two top stocks that you can buy and hold for a long time: NeoGenomics (NASDAQ: NEO) and Facebook (NASDAQ: FB). NeoGenomics runs a network of oncology-testing laboratories.
NeoGenomics (NEO) delivered earnings and revenue surprises of -200.00% and -0.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
MYERS, FL / ACCESSWIRE / May 5, 2020 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetic testing services, today announced a collaboration with Bayer (BAYN) to facilitate an RNA-based Neurotrophic Tropomyosin-Receptor Kinase (NTRK) testing for certain colorectal and thyroid cancer patients. All eligible patients who enroll and opt-in to a Sponsored Testing Program will receive testing at no cost to themselves or their insurance. Bayer will cover the total cost of this test regardless of the results and treatment decision.
American Revolution 2.0, which presents itself as bipartisan, has been assisted by far-right individuals – some with extremist linksLeaked audio recordings and online materials obtained by the Guardian reveal that one of the most prominent anti-lockdown prote…
Good morning! This is the tech news you need to know this Tuesday.
White supremacists have reportedly built a website that names, shames, and effectively promotes violence against interracial couples and families -- "and it's been circulated in some of the darkest corners of the internet, including in neo-Nazi Discord server…
FT. MYERS, FL / ACCESSWIRE / May 26, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Kathryn McKenzie, Chief Financial Officer ...
The CEO of surveillance firm Banjo, one of the many firms pitching law enforcement agencies across the country on artificial intelligence and big data-backed predictive policing, is leaving the company after an April report outed him as a former neo-Nazi skin…
Get books delivered to your doorstep to keep your kids occupied and off screens.
Q4 2019 Neogenomics Inc Earnings Call
Despite experiencing a double-digit decline in test volumes, the cancer genetics lab hasn't furloughed employees. It has even retooled labs to process COVID-19 swab and blood tests.
FORT MYERS, FL / ACCESSWIRE / May 26, 2020 / NeoGenomics, Inc. (NEO) (the "Company"), a leading provider of cancer-focused genetics testing services, announced today that it has formed a strategic collaboration with Inivata to commercialize the InVisionFirst-Lung liquid biopsy test in the United States. InVisionFirst-Lung is a ctDNA NGS liquid biopsy assay testing 37 genes relevant to the care of advanced non-small cell lung cancer (NSCLC) patients.
FORT MYERS, FL / ACCESSWIRE / April 30, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the " Company " ), a leading provider of cancer-focused genetics testing services, today announced the pricing of ...
FT. MYERS, FL / ACCESSWIRE / April 3, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused testing services, today announced that it has integrated Indica Labs enterprise-level HALO ...
Eye-tracking, wireless PC streaming, and a 4K display for under $1,000. Pico is pivoting to an enterprise-only strategy with its second-generation Neo VR headsets. The Pico Neo 2 and Pico Neo 2 Eye are standalone VR HMDs (head-mounted displays) that were u…
The entirety of the Neo Geo’s Samurai Shodown library—plus one that hasn’t seen the light of day since 2005—will soon be available in one complete package for PC, PlayStation 4, and Switch.Read more...
Get books delivered to your doorstep to keep your kids occupied and off screens.
New research published in the Proceedings of the National Academy of Sciences on Tuesday shows that the climate crisis may be seriously messing with North American birds’ migration patterns, and the consequences could be dire.Read more...
MYERS, FL / ACCESSWIRE / April 9, 2020 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetic testing services, provided a business update regarding the impact of the COVID-19 pandemic. NeoGenomics has implemented significant actions to protect its employees while maintaining a continuity of critical oncology testing for cancer patients. Among other actions, the Company has de-densified laboratories and facilities, adjusted laboratory shifts, restricted visitors to facilities, restricted employee travel, implemented an Emergency Paid Time Off policy, provided remote work-environment training and support, and managed its supply chains.
After looking at NeoGenomics, Inc.'s (NasdaqCM:NEO) latest earnings announcement (31 December 2019), I found it useful...
FT. MYERS, FL / ACCESSWIRE / April 1, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its first quarter 2020 ...
Was Devindra Hardawar wrong about something? Our fellow editor explains why he purchased a standalone Ultra HD Blu-ray player in 2020, after declaring the format “already lost” to streaming four years ago. Apparently the Xbox One X’s built-in player and strea…
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Good morning! This is the tech news you need to know this Wednesday.
Shares of genetic-testing company Invitae (NYSE: NVTA) rose over 13% today on an upbeat day for the stock market. The S&P 500 rose over 1.5% as investors cheered plans by some countries and U.S. states to soon begin reopening parts of their economies. While the broad economic damage caused by the coronavirus pandemic might take quarters or years to repair, the genetic testing industry might experience a faster recovery.
FT. MYERS, FL / ACCESSWIRE / May 11, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chairman and Chief Executive ...
Q1 2020 Neogenomics Inc Earnings Call
In addition, NeoGenomics expects to grant the underwriters of the offerings a 30-day option to purchase up to an additional (a) $15,000,000 of shares of its common stock at the public offering price, less underwriting discounts and commissions, and (b) $22,500,000 aggregate principal amount of the notes, less underwriting discounts and commissions and solely to cover over-allotments with respect to the notes offering. Neither the completion of the common stock offering nor the notes offering is contingent on the completion of the other. The underwriters of the common stock offering are also offering up to $40,000,000 of shares of NeoGenomics common stock borrowed from third parties (the "short sale") and will use the resulting short position to facilitate hedging transactions by some of the purchasers of the notes.
HBO Max is stuffed with cinematic classics from the Criterion Collection and various movie studios. We had a go at whittling it down.
Dual-screen computers are coming, but maybe not as soon as Microsoft first thought. The company originally planned to launch Windows 10X alongside new hardware -- the Surface Neo -- this holiday season. However, rumors from last month suggested that the forke…
First-Quarter 2020 Highlights: Consolidated revenue increased 10.9% to $106.0 million Clinical Services revenue increased 7.9% to $93.0 million Pharma Services revenue increased 39.3% to $13.0 million ...
NEO earnings call for the period ending March 31, 2020.